2-(2-(5-bromo-1H-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3H)-quinazolinone,
LY 225910,
LY225910,
133040-77-4,
LY 225910,
2-[2-(5-BROMO-1H-INDOL-3-YL)ETHYL]-3-[3-(1-METHYLETHOXY)PHENYL]-4-(3H)-QUINAZOLINONE,
CHEMBL37312,
LY225910,
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy )phenyl]-4-(3H)-quinazolinone,
KUECXUACQOYKNB-UHFFFAOYSA-N,
NCGC00024941-01,
Tocris-1018,
LY-225910,
AC1N95SI,
SCHEMBL9002941,
CHEBI:92592,
CTK8E7266,
HMS3267O07,
HMS3675P20,
ZINC2013702,
BDBM50006842,
MFCD00907856,
AKOS022180694,
AJ-32559,
CC-08387,
CJ-31218,
DB-042155,
RT-013607,
B6550,
FT-0643190,
LY225910, >=98% (HPLC),
C-35563,
L005998,
SR-01000597461,
J-006291,
SR-01000597461-1,
BRD-K33864865-001-01-7,
2-[2-(5-Bromoindol-3-yl)ethyl]-3-(3-isopropoxyphenyl)-4-quinazolinone,
2-(2-(5-Bromo-1H-indol-3-yl)ethyl)-3-(3-isopropoxyphenyl)quinazolin-4(3H)-one,
2-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one,
2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-(3-propan-2-yloxyphenyl)quinazolin-4-one,
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazoline,
4(3H)-Quinazolinone, 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-,
CID4355450,